The U.S. Food and Drug Administration, in coordination with the U.S. Department of Justice, has announced that the U.S. Marshals Service seized approximately 73,000 units of 7-hydroxymitragynine (7-OH) products valued at $1 million from three firms in Missouri.
FDA said the seizure focused on foods and dietary supplement products — including liquid shots and tablets — containing concentrated 7-OH as an added ingredient. Concentrated 7-OH is increasingly recognized as having potential for abuse because of its ability to bind to opioid receptors. It cannot be lawfully added to dietary supplements or conventional foods. These products are considered adulterated because 7-OH does not meet applicable safety standards. Also, the FDA has not approved 7-OH for medical use.
For comments and feedback contact: editorial@rttnews.com
Health News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.